PAR PHARMACEUTICAL COMPAINES, INC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for PAR PHARMACEUTICAL COMPAINES, INC

Sort by

Viewing results 1‒25 of 38

The Big Read
The inside story of the Pfizer vaccine: ‘a once-in-an-epoch windfall’
...Now, the US drugmaker is behind the pharmaceutical product with the record for sales in a single year....
November 30, 2021
The FT ViewThe editorial board
Vaccine protectionism by the EU will backfire
...The best, such as Denmark, are on a par with England at the same stage of rollout....
January 26, 2021
FT Live
Investing in America
Foreign companies as drivers of US growth, resilience and competitiveness
Tuesday, 10 DecemberHybrid Conference
News in-depthCoronavirus treatment
How AstraZeneca and Oxford found their vaccine under fire
...“We can definitely say that the transparency from Oxford and AstraZeneca has not been on a par with what we have seen from the others,” said Rasmus Bech Hansen, chief executive of Airfinity, a London-based...
November 27, 2020
Technology sector
Big hedge fund bet on NXP hit by trade war
...Those bonds had previously traded as high as 101 cents on the dollar, but were ultimately called at par. Qualcomm also sought to buy some of its debt back at par. The cases are often more extreme....
July 20, 2018
Pharmaceuticals sector
Indivior warns of threat to key opioid addiction treatment after legal setback
...Watson Pharmaceuticals and Par Pharmaceutical have previously been prevented from working on a generic film alternative, but Indivior said the latest ruling means they “are now able to pursue their respective...
September 1, 2017
FT AlphavilleSiona Jenkins
Opening Quote: Indivior suffers legal setback on opioid treatment
...Watson Pharmaceuticals and Par Pharmaceutical have previously been prevented from working on a generic film alternative, but Indivior said the latest ruling means they “are now able to pursue their respective...
September 1, 2017
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
News in-depthUS & Canadian companies
MAmazon makes its move in healthcare
...When Amazon bought a big stake in drugstore.com in 1999, Jeff Bezos thought he could do for pharmaceuticals what he had done for books, stealing market share from bricks-and-mortar pharmacies and bringing...
January 31, 2018
Pharmaceuticals sector
Mylan drops as AGs look to expand generic drug-pricing lawsuit
...Reddy’s Laboratories, Inc.; Emcure Pharmaceuticals, Ltd.; Glenmark Pharmaceuticals, Inc.; Lannett Company, Inc.; Par Pharmaceutical Companies, Inc.; Sandoz, Inc.; Sun Pharmaceutical Industries,Inc.; and...
October 31, 2017
US equities
Drugmaker Endo rises on leadership change
...Mr Campanelli previously served as chief executive of Par Pharmaceutical and joined Endo after the company bought Par in 2015....
September 23, 2016
UK banks
Week in Review: January 28
...The company also helped to assuage investor fears over the margins of its newer growth businesses, by disclosing a commercial cloud gross margin of 48 per cent — on par with the previous quarter....
January 27, 2017
UK equities
Supermarkets in retreat on Asda war signal
...Dechra Pharmaceuticals, the veterinary medicines maker, was down 3.7 per cent to £11.34 after Jefferies restarted coverage with “hold” advice....
June 3, 2016
High yield bonds
Healthcare junk bonds sting investors
...Dealmakers have struck $460bn in M&A transactions in healthcare since the year began, including Valeant’s $15.8bn deal for Salix, as well as Endo’s purchase of Par Pharmaceutical from TPG Capital and Mallinckrodt...
October 1, 2015
LexUS & Canadian companies
Endo/Par: too much of a good thing
...Why, then, is the market so tepid on Endo’s $8bn cash and stock purchase of Par, a generics company? After Monday’s announcement, Endo’s shares fell 5 per cent....
May 18, 2015
US & Canadian companies
Endo to buy Par from TPG Capital in $8bn cash-and-shares deal
...The deal is the latest in a feverish game of brinkmanship being played out by some of the biggest companies in the pharmaceuticals sector....
May 18, 2015
US equities
Ann leaps after Ascena declares intentions
...Endo International shares fell 5.37 per cent to $80.77 after the drugmaker announced that it would acquire privately held Par Pharmaceutical for $8.05bn in shares and cash, from TPG....
May 18, 2015
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Pharmaceuticals sector
Australia’s CSL warns of biotech bubble
...This has coincided with a wave of M&A activity in the pharmaceutical and healthcare sector, including Shire’s US$30bn hostile takeover approach last week to US drugmaker Baxalta — a key competitor of CSL...
August 10, 2015
US & Canadian companies
Week in Review, January 17
...He also predicted that his group would be selling “a few million” vehicles — on a par with BMW — by 2025, despit e a slowdown of sales in China....
January 16, 2015
US & Canadian companies
Activist hedge fund Elliott to push for Interpublic sale
...A battle to force the Swiss pharmaceutical group Actelion to sell itself in 2011 was defeated and Elliott sold its stake in the company....
July 24, 2014
Mergers & Acquisitions
Shire jumps on renewed bid speculation
...GW Pharmaceuticals soared 36 per cent to 305.5p after Morgan Stanley started coverage of the cannabis-based painkiller developer....
April 22, 2014
US equities
Ruby Tuesday tumbles on quarterly loss
...Acura Pharmaceutical, the speciality pharmaceutical company said it had settled with both Par Pharmaceutical Companies and Impax Laboratories in a patent infringement case related to Acura’s pain drug Oxecta...
October 10, 2013
Technology sector
DeepMind and NaturalMotion lead charge of London’s tech start-ups
...The applications for Aqdot’s capsules range from agriculture to pharmaceuticals and cleaning products....
February 10, 2014
US & Canadian companies
TPG picks up Par Pharmaceuticals
...Par Pharmaceutical would be the fifth largest drug sector buyout since 2000, according to Dealogic....
July 16, 2012
LexUS downturn
PIK-Toggle/Dividends – rich pickings
...Investors will be paid a yield of 10 per cent (if the bonds trade at par)....
October 10, 2012
US & Canadian companies
HGSI fights GSK bid with ‘poison pill’
...GSK refused to participate in the process and launched its offer....
May 17, 2012
US & Canadian companies
Buy-out groups in $3.9bn deal to acquire PPD
...PPD is a contract research organisation for pharmaceutical, biotech and medical device companies....
October 3, 2011

Previous pagePage 1 of 2Next page